Showing results (251-260 of 267) with videos related to
Sort By:
Pageof 27
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 7, 2008
The use of low-energy laser (LEL) for the prevention of chemotherapy- and/or radiotherapy-induced oral mucositis in cancer patients: results from two prospective studiesM T Genot-Klastersky, J Klastersky, F Awada, et al.Patient Education and Counseling|March 13, 2016
Predictors of physicians' satisfaction with their management of uncertainty during a decision-making encounter with a simulated advanced stage cancer patientY Libert, D Canivet, C Ménard, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2009
A general chemotherapy myelotoxicity score to predict febrile neutropenia in hematological malignanciesM Moreau, J Klastersky, A Schwarzbold, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, G Bureau, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancerJ P Sculier, J J Lafitte, J Lecomte, et al.Revue Des Maladies Respiratoires|March 13, 1998
[Prognostic factors in advanced stage non-small cell bronchial cancer: experiences of the European Lung Cancer Working Party]J P Sculier, M Paesmans, P Libert, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, J Thiriaux, et al.British Journal of Cancer|October 12, 2000
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancerJ P Sculier, J J Lafitte, M Paesmans, et al.European Journal of Cancer (Oxford, England : 1990)|February 5, 2000
A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, J Thiriaux, et al.Lung Cancer (Amsterdam, Netherlands)|December 1, 1996
Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer. (NSCLC)M Borges, J P Sculier, M Paesmans, et al.Pageof 27